News room
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment
Regulatory
April 20, 2022
Egetis Therapeutics’ 2021 annual report published
Regulatory
March 30, 2021
Egetis Therapeutics 2020 annual report published
Regulatory
April 8, 2019
August 19, 2022
Half-year report January - June
August 24, 2022
Erik Penser Bank Bolagsdag
Share
Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden
Phone: +46 8 679 72 10
E-mail: info@egetis.com
